PATENT CLAIM ANALYSIS

Application Number: 15880970
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-06
Patent Classification: ["424", "186100"]

Abstract:
The present invention is directed to a sequence modification of the H7 hemagglutinin glycoprotein of the Influenza A/Shanghai/2/2013 H7 sequence together with vaccines derived therefrom. In addition, the invention further comprises method for improving the efficacy of vaccine antigens by modifying T cell epitopes.

Claim (Index 69):
The method according to  claim 67 , wherein said modifications introduces introduce a T cell epitope that engages effector T cells.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 86.0
- Lexical Diversity: 1.23684
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15571040', '15536857', '11802106', '12096322', '14910136']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7641296193337572
- 35 USC 102 Novelty (BERT): 0.5783570251192374
- Combined Prediction Score: 0.7455523599123053
- Mean Citation Score: 380.510298
- Max Citation Score: 641.51917
- Similarity Product: 350.65566824187044

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test